![Page 1: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/1.jpg)
1
KSU, Collage of Medicine, Department of pharmacology .KSU, Collage of Medicine, Department of pharmacology .Prepared by : Narmeen Al-Bashrawi.Prepared by : Narmeen Al-Bashrawi.Supervised by : Dr Hanan Hajar.Supervised by : Dr Hanan Hajar.
![Page 2: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/2.jpg)
2
Objective: Introduction to cyclosporine. Chemical structure. Physical properties. Formulation. Pharmacodynamic of cyclosporine. Pharmacokinetic of cyclosporine. Indication. Contraindicating. Adverse effects. Drug food interacting. Drug – drug interaction.
![Page 3: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/3.jpg)
3
Introduction:
Cyclosporine was first isolated from the fungus Tolypocladium inflatum and originally thought to be an antifungal antibiotic with minimal clinical value.
![Page 4: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/4.jpg)
4
introduction cont
![Page 5: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/5.jpg)
5
Introduction cont
Its immunosuppressive activity was first detected by Borel in 1976 who discovered that cyclosporine was relatively nontoxic to bone marrow and remarkably immunosuppressive
![Page 6: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/6.jpg)
6
Chemical structure:
Cyclosporine is a cyclic polypeptide immunosuppressant agent consisting of 11 amino acid.
![Page 7: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/7.jpg)
7
chemical structure cont
![Page 8: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/8.jpg)
8
Physical properties:
Cyclosporine have a molecular weight of 1202.6 and occurs as a white solid with a melting point of 148°C to 151°C (natural) and 149°C to 150°C (synthetic).
slightly soluble in water and soluble in organic solvents.
![Page 9: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/9.jpg)
9
Cyclosporine formulation: 1-Sandimmune (Cyclosporine) Soft Gelatin . 2-Sandimmune Oral Solution . 3-Sandimmune Injection .
![Page 10: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/10.jpg)
10
Pharmacodynamic Properties
![Page 11: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/11.jpg)
11
Pharmacodynamic Properties:
1-Mechanism of action
![Page 12: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/12.jpg)
12Mechanism of Mechanism of actionaction
![Page 13: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/13.jpg)
13
Mechanism of action
Cyclosporine is lipophilic peptide that easily crosses the membranes cells, such as T lymphocytes.
Its effects depending on binding to cytosol proteins (cyclophilin). The drug-immunophilin complex in turn bind to calcineurine .
![Page 14: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/14.jpg)
14
Mechanism of action cont
As a result, the transcription factor is enabled to enter the nucleus, which is the essential step for the activation and transcription of certain genes interleukin-2 by T lymphocyte.
leading to Reduce the migration of monocytes to the targt and helping to protect the transplanted organ from normally aggressive host defense mechanisms .
![Page 15: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/15.jpg)
15Mechanism of Mechanism of actionaction
![Page 16: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/16.jpg)
16
Pharmacodynamic Properties cont:
2-Pharmalogical Effects
![Page 17: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/17.jpg)
17
2-Pharmalogical effects:
kidney: In the kidney, cyclosporine produced structural and
functional changes predominantly affecting the: proximal tubule The afferent arteriole. Increased thronboxane A2 levels cause renal
vasoconstriction and proliferation of vascular smooth muscle cells into the intimae.
Reduced the release of vasodilatory kinins. So , Cyclosporine has an indirect vasoconstrictor effect,
which has been associated with hypertension and renal dysfunction
![Page 18: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/18.jpg)
18
Pharmalogical effects cont
cardiovascular system : Blood pressure and cardiac hypertrophy: The principle cause of hypertension after
organ transplantation is the treatment with a cyclosporine which is (CIN).
The price mechanism(s) are not known.
![Page 19: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/19.jpg)
19
Pharmalogical effects cont
Lipid metabolisms and athergenic profile:The pathogenesis of impaired lipid metabolism
with cyclosporine has not fully elucidated . Glucose metabolism:Cyclosporine maintain insulin resistance but
decrease insulin secretion (may predispose to post tranplantation diabetes mellitus PTDM) dose-depended and reversible .
![Page 20: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/20.jpg)
20
Pharmalogical effects cont
3-Others: Dose-dependent elevation of liver
function test without histological abnormality.
Activation of sympathetic system. does not cause bone marrow suppression
.
![Page 21: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/21.jpg)
21
Pharmacokintic Properties
![Page 22: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/22.jpg)
22
Pharmacokintic Properties
Absorption: Absorption is dependent on the presence of bile and
there for prone to variability.
the drug is poorly absorbed, Variable and incomplete from gastrointestinal tract after oral administration with a bioavailability of about 30% (range 5% to 70%).
The original cyclosporine formula showed high intra- and inter-patient variability and low bioavailability.
![Page 23: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/23.jpg)
23
Pharmacokintic Properties cont
A microemulsion Neural was introduced To address the wide intra and interindividual differences in absorption, distribution, metabolism, and elimination of the oil-based formulation of cyclosporine (Sandimmune).
![Page 24: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/24.jpg)
24
Pharmacokintic Properties cont
![Page 25: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/25.jpg)
25
Different between sandimmune and Neoral
Sandimmune Neoral
FORMULA Oil-based formula microemulsion
ABSORPTION Need more bile Less bile require
FOOD Increase absorption Less affected
BIOAVALIBILITY 30% (5-70) Better
PEAK 3.5 h 1.2-2h
VARABILITY More Less
OUT COME Improve outcome(less acute rejection)
![Page 26: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/26.jpg)
26
Pharmacokintic properties cont
C2 monitoring allow a more accurate and reliable evaluation of cyclosporine exposure
Maintaining organ transplant patients. Identify a significant percentage of
overexposed subject. Possibly limiting the rate of progression of
chronic graft dysfunction .
![Page 27: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/27.jpg)
27
Pharmacokintic properties cont
2-Distribution:
plasma, 33%-47%
erythrocyte, 41%-58%
lymphocytes, 4%-9%
granulocytes, 5%-12%
plasma
erythrocyte
granulocytes
lymphocytes
![Page 28: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/28.jpg)
28
Pharmacokintic properties cont
3-Metabolism: cytochrome P450 enzyme (CYP3A4) in the liver
(mainly), and for leaser extent in small intestine. Glycoprotein P is a transport protein present in the
brush border of the human small intestine that functions to pump sub strates, including cyclosporine, back into the intestinal lumen against an absorption gradient.
![Page 29: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/29.jpg)
29
Pharmacokinetic properties cont
Variation in liver CYP3A4 is the major con tributor to overall variability in oral Cyclosporine metabolism. Changes in Cyclosporine formulations may reduce but will not entirely eliminate significant intra- and interaction differences in cyclosporine metabolism.
![Page 30: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/30.jpg)
30
Pharmacokintic properties cont
Half life:
Children—Approximately 7 hours (range, 7 to 19 hours).
Adults—Approximately 19 hours (range, 10 to 27 hours).
![Page 31: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/31.jpg)
31
Pharmacokintic properties cont
Excretion: Elimination is primarily biliary. only 6% of the dose (parent drug and
metabolites) excreted in the urine. 0.1% of a cyclosporine dose is excreted
unchanged in the urine
![Page 32: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/32.jpg)
32
Uses of Cyclosporine
![Page 33: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/33.jpg)
33
Uses of Cyclosporine cont
1- Systemic indication
![Page 34: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/34.jpg)
34
Uses of Cyclosporine cont
Organ transplantation to prevent graft rejection in kidney, liver, heart, lung, and combined heart-lung transplants.
It is used to prevent rejection following bone marrow transplantation and Prophylaxis of graft-versus-host disease.
Treatment of chronic rejection in patients previously treated with other immunosuppressant.
![Page 35: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/35.jpg)
35
Uses of Cyclosporine cont
A treatment of autoimmune diseases. Cyclosporine therapy in severe ulcerative colitis,
refractory to steroids . Tacrolimus – related adverse effects . Psoriasis. Atopic dermatitis. Rheumatoid arthritis. Nephrotic syndrome(steroid-dependent and
steroid-resistant nephrotic syndrome ) .
![Page 36: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/36.jpg)
36
Uses of Cyclosporine cont
Cyclosporine remains as the mainstay of anti rejection treatments in patients especially undergoing solid organ transplants .
![Page 37: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/37.jpg)
37
Uses of Cyclosporine cont
2- Opthalmic indication
![Page 38: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/38.jpg)
38
Uses of Cyclosporine cont
Cyclosporine is useful for patients with various inflammatory ocular surface disorders.
reversing inflammation of the ocular surface and lacrimal glands .
improving the signs and symptoms of dry eye syndrome.
Keratoconjunctivitis sicca (treatment) . Neurotrophic keratopathy . Atopic keratoconjunctivitis.
![Page 39: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/39.jpg)
39
Contraindication of Cyclosporine
![Page 40: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/40.jpg)
40
Contraindication of Cyclosporine
Sensitivity to cyclosporine Malignancy, current or Premalignant skin lesions. Chickenpox, existing or recent, or Herpes zoster
(risk of severe generalized disease). Hepatic function impairment Hyperkalemia hypertension Infection Malabsorption Renal function impairment (dose reduction).
![Page 41: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/41.jpg)
41
Cyclosporine adverse effect
![Page 42: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/42.jpg)
42
Cyclosporine adverse effect
1-Cyclosporine Nephrotoxicity:
Cyclosporine toxicity is classified in two phases: An acute, functional, dose-dependent decrease in
renal blood flow and glomerular filtration rate (GFR), and
A chronic, dose- independent form with structural changes leading to a progressive and persistent decrease in GFR .
![Page 43: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/43.jpg)
43
Cyclosporine adverse effect cont
Nephrotoxicity correlates with drug exposure, C2 measurements of blood concentrations early after transplantation (unlike trough levels C0) are likely to serve as an accurate tool for the avoidance of both under immunosuppression and toxicity.
![Page 44: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/44.jpg)
44
Cyclosporine adverse effect cont
2-Cardiovascular toxicity
Cardiovascular disease is one of the major causes of mortality and morbidity.
arterial hypertension in 50% to 80%. high total cholesterol level. high low density lipoprotein(LDL) . de novo post trasplant diabetes mellitus.
![Page 45: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/45.jpg)
45
Cyclosporine adverse effect cont
3-hypertention: Chronic arterial hypertension, increasing with
time after transplantation, is associated with decrease allograft survival.
4-hyperlipidaemia.5- De novo post transplant diabetes mellitus
(PTDM): Diabetes mellitus has become one of the most
common causes of renal failure .
![Page 46: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/46.jpg)
46
Cyclosporine adverse effect cont
6-Gingival hypertrophy :
Gingival hyperplasia is usually reversible within 6 months after withdrawal of cyclosporine.
![Page 47: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/47.jpg)
47
Cyclosporine adverse effect cont
7-Other adverse effects: human carcinogen (mainly lymphoma or
skin cancer ). facial dimorphism . Dose dependent hyperkalemia( tubular
aldosteroine insensitivity ). Post-transplant lymphoproliferative
disorders. Gastrointestinal disturbances.
![Page 48: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/48.jpg)
48
Cyclosporine adverse effect cont
Respiratory: breathing difficulties .
Hematopoietic:Leukopenia .
hyperuricemia and gout.
hypomagnesaemia ( clearance).
![Page 49: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/49.jpg)
49
Cyclosporine adverse effect cont
Central Nervous System: convulsions, headache
Autonomic Nervous System: Paresthesia
SKIN: Hirsutism , Acne.
vulnerability to opportunistic fungal and viral infections.
![Page 50: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/50.jpg)
50
Cyclosporine adverse effect cont
In general about adverse effect: Cyclosporine had a narrow therapeutic range (fine line
between adequate immunosuppressant and the risk of drug-induced side effect) .
Variable Cyclosporine exposure is now believed to be a key determinant of acute rejection, chronic rejection,which is the principle cause of late graft loss.
Thus optimal therapy with cyclosporine requires predictor of drug exposure and a clear rang of therapeutic level.
![Page 51: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/51.jpg)
51
Cyclosporine Interactions
![Page 52: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/52.jpg)
52
Cyclosporine Interactions
1-with Dietary Supplements
![Page 53: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/53.jpg)
53
Cyclosporine Interactions with Dietary Supplements
Vitamin ECombining vitamin E and cyclosporine requires medical
supervision to avoid cyclosporine toxicity.
Omega 3 fatty acid.(reduce high blood pressure).
Food (increases the absorption of cyclosporine ) Grape fruit juice (increase in cyclosporine
blood ).
![Page 54: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/54.jpg)
54
Cyclosporine Interactions
2-Drug – drug interactin
![Page 55: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/55.jpg)
55
Cyclosporine Interactions cont
Cyclosporine is extensively metabolized by cytochrome P-450 3A. Substances that inhibit this enzyme could decrease metabolism and increase cyclosporine concentrations .
![Page 56: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/56.jpg)
56
Cyclosporine Interactions cont
Drugs That May Potentiate Renal Dysfunction
AntibioticsAntibiotics AntineoplasticAntineoplastic Anti-Anti-Inflammatory Inflammatory DrugsDrugs
GastrointestiGastrointestinal Agentsnal Agents
Gentamicin Gentamicin Melphalan Melphalan AzapropazonAzapropazon Cimetidine Cimetidine
Tobramycin Tobramycin Diclofenac Diclofenac Ranitidine Ranitidine
Vancomyci-Vancomyci-n n
Antifungals Antifungals Naproxen Naproxen
TrimethopriTrimethopri-m -m
Amphotericin B.Amphotericin B. SulindacSulindac ImmunosuppresImmunosuppressives sives
Sulfametho-Sulfametho-xazole xazole
ketoconazole ketoconazole Colchicine Colchicine Tacrolimus Tacrolimus
![Page 57: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/57.jpg)
57
Cyclosporine Interactions cot
Calcium Calcium Channel Channel BlockersBlockers
AntifungalsAntifungals AntibioticsAntibiotics GlucocortiGlucocorticoidscoids
Diltiazem Diltiazem Fluconazole Fluconazole Clarithromycin Clarithromycin MethylpredMethylprednisolone nisolone
NicardipinNicardipine e
ItraconazoleItraconazole ErythromycinErythromycin
VerapamilVerapamil KetoconazoleKetoconazole QuinupristinQuinupristinDalfopristin Dalfopristin
Drugs That Increase Cyclosporine Concentrations
![Page 58: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/58.jpg)
58
Cyclosporine Interactions cont
AntibioticsAntibiotics AnticonvulsantAnticonvulsantss
Other Other Drugs/Dietary Drugs/Dietary SupplementsSupplements
Nafcillin Nafcillin CarbamazepinCarbamazepine e
Octreotide Octreotide
Rifampin Rifampin Phenobarbital Phenobarbital Ticlopidine Ticlopidine
Phenytoin Phenytoin Orlistat Orlistat
Drugs/Dietary Supplements That Decrease Cyclosporine Concentrations
![Page 59: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/59.jpg)
59
Cyclosporine Interactions cont
Note thatNote that:: Reduction in the blood concentrations of
cyclosporine, resulting in subtherapeutic levels, rejection of transplanted organs, and graft loss.
Cyclosporine may reduce the clearance of digoxin.
Severe digitalis toxicity has been seen within days of starting cyclosporine in several patients taking digoxin .
![Page 60: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/60.jpg)
60
![Page 61: 1 KSU, Collage of Medicine, Department of pharmacology. Prepared by : Narmeen Al-Bashrawi. Supervised by : Dr Hanan Hajar](https://reader030.vdocuments.site/reader030/viewer/2022033023/56649c7c5503460f949306e9/html5/thumbnails/61.jpg)
61
Thank you for your Thank you for your attentionattention